Taiwan Liposome Company, Ltd. (TLC) Earning

NASDAQ Currency in USD Disclaimer

$7.00

north_east NA Past Year
Day's range
$7
Day's range
$7.09

Taiwan Liposome Company, Ltd. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
06/29/2021 Q2 2021 -$1.79 $160.18 M
03/30/2021 Q1 2021 -$4.78 $37.62 M
12/30/2020 Q4 2020 -$6.96 $12.08 M
09/29/2020 Q3 2020 -$5.56 $66.10 M
06/29/2020 Q2 2020 -$6.56 $11.78 M
03/30/2020 Q1 2020 -$5.80 $11.97 M
12/30/2019 Q4 2019 -$8.60 $11.95 M
09/29/2019 Q3 2019 -$5.60 $18.84 M
06/29/2019 Q2 2019 -$7.58 $20.59 M
03/30/2019 Q1 2019 -$3.52 $157.77 M
12/30/2018 Q4 2018 -$10.94 $17.38 M
09/29/2018 Q3 2018 -$7.04 $15.28 M
06/29/2018 Q2 2018 -$8.36 $15.57 M
03/30/2018 Q1 2018 -$5.98 $14.09 M
12/30/2017 Q4 2017 -$9.40 $12.40 M
09/29/2017 Q3 2017 -$8.06 $13.37 M
06/29/2017 Q2 2017 -$8.18 $12.01 M
03/30/2017 Q1 2017 -$5.74 $11.86 M
12/30/2016 Q4 2016 -$9.61 $12.64 M
09/29/2016 Q3 2016 -$8.48 $9.82 M
 

Taiwan Liposome Company, Ltd. Earnings: FAQ's

Did Taiwan Liposome Company, Ltd. beat their earnings estimates last quarter?

In the previous quarter, Taiwan Liposome Company, Ltd. (:TLC) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.09.

How can I listen to Taiwan Liposome Company, Ltd.'s earnings conference call?

The conference call for Taiwan Liposome Company, Ltd.'s latest earnings report can be listened to online.

How can I read Taiwan Liposome Company, Ltd.'s conference call transcript?

The conference call transcript for Taiwan Liposome Company, Ltd.'s latest earnings report can be read online.

How much revenue does Taiwan Liposome Company, Ltd. generate each year?

Taiwan Liposome Company, Ltd. (:TLC) has a recorded annual revenue of $101.93 M.

How much profit does Taiwan Liposome Company, Ltd. generate each year?

Taiwan Liposome Company, Ltd. (:TLC) has a recorded net income of $101.93 M. Taiwan Liposome Company, Ltd. has generated $-24.89 earnings per share over the last four quarters.

What is Taiwan Liposome Company, Ltd.'s price-to-earnings ratio?

Taiwan Liposome Company, Ltd. (:TLC) has a price-to-earnings ratio of -9.29 and price/earnings-to-growth ratio is -0.09.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED